Real-world evidence provider Aetion announced a deal to acquire Replica Analytics, an artificial intelligence-powered solution that produces synthesized health care data. Aetion will merge Replica’s technology into its Evidence Platform in an effort to improve data offerings. Replica Analytics Co-founder and CEO Khaled El Emam said the partnership will allow Replica to "accelerate and expand" its mission of protecting privacy while making health data "responsibly accessible." Editor's note: El Emam wrote about synthetic data for the IAPP's Privacy Tech.
If you want to comment on this post, you need to login.